Pluri Inc. Selling, General and Administrative Expense
Pluri Inc. (PLUR) reported Selling, General and Administrative Expense of $1.68 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2020-05-11
- Pluri Inc. selling, general and administrative expense for the quarter ending 2020-03-31 was $1.68M, a 31.99% decline year-over-year.
- Pluri Inc. selling, general and administrative expense for the quarter ending 2019-03-31 was $2.47M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 9 month |
|---|---|---|
| 2020-03-31 | $1.68M 10-Q · filed 2020-05-11 | $5.25M 10-Q · filed 2020-05-11 |
| 2019-03-31 | $2.47M 10-Q · filed 2020-05-11 | $6.81M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |